Education, Conference Coverage and Articles
Dr Laurence Dobbie discusses a new European consensus statement highlighting the nutritional, functional and psychological considerations needed to support safe, effective and equitable use of incretin-based therapies in obesity management.
Your clinical career is shaped not only by what you know, but by who helps you navigate what comes next. Join us for the final episode in our mini-series exploring non-clinical skills that can help you thrive in your clinical career. Today we explore how to develop the right team around you to support your work, and what building that bench can mean for your career, and the life you build alongside it.
In this interview, Diana Isaacs shares her highlights from the 2026 AACE Annual Meeting, discussing key advances in diabetes management, obesity treatment and diabetes technology, alongside emerging priorities for future endocrinology research and guideline development.
Omnipod 5 real-world case studies.
Using Omnipod 5 for exercise.
New data presented at the Advanced Technologies & Treatments for Diabetes 2026 highlight a shift in diabetes care beyond glucose control alone. Emerging evidence supports the growing role of incretin-based therapies such as semaglutide, alongside advances in continuous glucose monitoring systems including Dexcom G7 and Freestyle Libre 3. Together, these innovations demonstrate meaningful improvements in glycemic outcomes, cardiometabolic risk, and patient behaviors, signaling a move toward more personalized, integrated approaches to diabetes management across both type 1 and type 2 diabetes.
We often focus on clinical excellence, but spend less time developing broader skills that could help us better lead with purpose and build more fulfilling, impactful careers. In this episode, part of a mini-series in partnership with LEADderm, Dr Jennifer Soung and Denise Mann explore how clinicians can engage with the media to educate, empower and extend their impact beyond the clinic.
The UK National Screening Committee has opened a public consultation on universal newborn screening for biliary atresia. Although early detection improves outcomes, current evidence on dried blood spot biomarkers and stool colour cards remains insufficient for population screening. Stakeholders are invited to submit evidence by 20 May 2026.
February is Rare Liver Diseases Month, bringing global attention to policy, education and advocacy needs surrounding rare liver conditions. During this month, the Global Liver Institute leads its annual #RareAware campaign to highlight the importance of early detection and access to care. With more than 100 rare liver diseases often going unrecognised, greater awareness helps patients receive timely support and empowers families to make informed decisions and advocate confidently for their care.
The European Association for the Study of Diabetes (EASD) Early Career Academy (ECA) has rapidly become a central initiative supporting the professional development of emerging clinicians and researchers in diabetology. Established to foster mentorship, collaboration and career progression, the Academy ...
touchENDOCRINOLOGY Future Leaders 2026 Following the successful introduction of touchENDOCRINOLOGY Future Leaders 2025, we are delighted to announce that nominations are now open for the 2026 edition. This initiative celebrates the next generation of endocrinology pioneers, those whose passion, dedication and innovative ...
Drawing on the experience of expert faculty and emerging leaders who have already navigated many of the early hurdles when embarking on a career in endocrinology, we asked for one piece of career advice to share with those just starting out. Their reflections highlight the importance of curiosity, compassion, adaptability and purpose in building a fulfilling and sustainable career.
There is no doubt that artificial intelligence was one of the fastest-moving technologies of 2025. Advances in predictive analytics, pattern recognition across large datasets, and the integration of genomic, phenotypic and real-world data are already beginning to reshape how clinicians diagnose disease, stratify risk and personalise care. We asked some of the experts that have collaborated with touchENDOCRINOLOGY what excites them most about AI and how they see it influencing clinical practice.
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
Keep track of your clinical interests and newsletter subscriptions.
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.
Or use a Social Account.
Already registered? Login below.